Vanguard Capital Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.49M Sell
4,008,963
-22,321
-0.6% -$27.4K ﹤0.01% 3119
2026
Q2
$4.96M Buy
4,031,284
+49,468
+1% +$49.3K ﹤0.01% 3122
2026
Q1
$2.8M Buy
+3,981,816
New +$3.72M ﹤0.01% 3258

Other funds holding MXCT

Vanguard Capital Management's MXCT Position: Q3 2026 in Review

Vanguard Capital Management reduced its MaxCyte (MXCT) stake by 0.55% in Q3 2026, selling an estimated $27.4K and leaving 4,008,963 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Vanguard Capital Management first reported a position in MXCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.96M in Q2 2026. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • Vanguard Capital Management held 4,008,963 shares of MaxCyte worth $4.49M as of Q3 2026.
  • Vanguard Capital Management sold 22,321 MaxCyte shares in Q3 2026, an estimated $27.4K.
  • MaxCyte made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3119 holding.
  • Vanguard Capital Management first reported a position in MaxCyte in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's MaxCyte position peaked at $4.96M in Q2 2026.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.